Thymosin Alpha 1 (Tα1) is a naturally occurring peptide originally isolated from the thymus gland. It consists of 28 amino acids and plays a central role in immune system regulation, particularly in the maturation and activation of T-cells.
Unlike many peptides used in anti-aging or performance contexts, Thymosin Alpha 1 is primarily valued for its immunomodulatory properties. It has been approved in over 35 countries for the treatment of hepatitis B and C and is used as an adjunct in cancer immunotherapy protocols.
Thymosin Alpha 1 is not FDA-approved in the United States but is available through compounding pharmacies and is commonly used off-label in integrative and peptide therapy clinics for immune support.
Clinical evidence is strongest for chronic hepatitis treatment; other uses are supported primarily by preclinical and observational data.
Thymosin Alpha 1 modulates the immune system through several key pathways:
These actions make Tα1 a broad-spectrum immune enhancer rather than a simple immune stimulant.
A controlled trial demonstrating that Thymosin Alpha 1 improved sustained virological response in chronic hepatitis B patients.
This review examined the immunomodulatory mechanisms of Thymosin Alpha 1, including its effects on dendritic cells and Toll-like receptor signaling.
Researchers reviewed the use of Thymosin Alpha 1 as an adjunct to chemotherapy and immunotherapy, noting improved immune parameters in cancer patients.
A meta-analysis showing that Thymosin Alpha 1 supplementation reduced mortality in patients with severe sepsis by restoring immune function.
If you're using a browser with advanced ad blocking security measures, the above study links may not work. You can copy the link and paste it into a new window.
Disclaimer: The information on this page was generated with the assistance of artificial intelligence and compiled from publicly available sources. While efforts are made to ensure accuracy, information may be incomplete, outdated, or incorrect and should not be relied upon as medical advice.
R2 Medical Clinic uses medications sourced from compounding pharmacies. Compounded drugs have not been approved by the FDA; have not been reviewed by the FDA for safety, efficacy, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. The processes by which the compounded drugs are manufactured have not been reviewed by the FDA. FDA approved products containing semaglutide and tirzepatide are available.